Treatment of secondary pulmonary hypertension with bosentan after left ventricular assist device implantation

Cardiovascular Therapeutics
Shane J LaRueJoel D Schilling

Abstract

Secondary pulmonary hypertension (PH) and right ventricular dysfunction are common and associated with poor prognosis in HF patients with left ventricular assist devices (LVADs). The role of pulmonary vasodilator therapy for these patients is currently unclear. We sought to evaluate the safety and clinical course of patients treated with bosentan, an endothelin receptor antagonist, after the implementation of a LVAD. Between 10/2008 and 5/2011, 50 consecutive patients with mean PAP >25 mmHg were treated with bosentan after LVAD implantation for a mean duration of 15.7 (±12.4) months. Ten patients discontinued the drug for possible side effects, including three for LFT abnormalities. Comparison of baseline to 6-month follow-up data revealed laboratory evidence for decongestion with a decrease in bilirubin (2.3-0.6, P < 0.0001) and an improvement in pulmonary hemodynamics with echocardiographically calculated mean PVR decreasing 1.4 woods units (3.93 ± 1.53 to 2.58 ± 1.05, P < 0.0001). In this single-centered retrospective case series, we provide evidence that the tolerability of bosentan in LVAD-supported patients with secondary PH is comparable to prior experience in patients with heart failure.

References

Nov 30, 1999·Journal of the American College of Cardiology·J ButlerJ R Wilson
Aug 11, 2000·European Journal of Heart Failure·P Mylona, J G Cleland
Mar 22, 2002·The New England Journal of Medicine·Lewis J RubinGerald Simonneau
Mar 26, 2003·Journal of the American College of Cardiology·Amr E AbbasSteven J Lester
Aug 17, 2005·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Patricia P ChangEdward K Kasper
Jan 10, 2006·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Nicholas C DangYoshifumi Naka
Apr 28, 2007·The Annals of Thoracic Surgery·Christian D EtzChristof Schmid
Aug 19, 2009·Vascular Health and Risk Management·Christopher J Valerio, John G Coghlan
Oct 8, 2009·Circulation. Heart Failure·Ryan J TedfordHunter C Champion
Feb 2, 2010·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Pradeep K NairMarc A Simon
Feb 6, 2010·The Journal of Thoracic and Cardiovascular Surgery·Robert L KormosUNKNOWN HeartMate II Clinical Investigators
Mar 30, 2010·The American Journal of Cardiology·Stavros G DrakosPatrick W Fisher
Sep 28, 2012·Journal of Artificial Organs : the Official Journal of the Japanese Society for Artificial Organs·Teruhiko ImamuraRyozo Nagai
Feb 14, 2013·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Jeffrey A MorganRobert J Brewer
Oct 4, 2013·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Koji TakedaHiroo Takayama
Nov 12, 2013·Circulation. Heart Failure·Meredith A BriscoJeffrey M Testani
May 27, 2014·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·James K KirklinJames B Young

❮ Previous
Next ❯

Citations

Sep 15, 2015·The Journal of Thoracic and Cardiovascular Surgery·Christian A Bermudez, J Eduardo Rame
Jun 1, 2016·Current Heart Failure Reports·Christopher W JensenY Joseph Woo
May 8, 2020·Cardiac Failure Review·Sriram D RaoJeremy A Mazurek
Jul 12, 2019·Current Heart Failure Reports·Sriram D RaoJeremy A Mazurek
Jul 12, 2017·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Ashwin K RavichandranJoel D Schilling

❮ Previous
Next ❯

Related Concepts

Related Feeds

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.

© 2022 Meta ULC. All rights reserved